Laura Schirosi

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 5

Top Topics

Epidermal Growth Factor Receptor

Top Venues

Current oncology (Toronto, Ont.)

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Lauro Bucchi, Alessandra Ravaioli, Luigino Dal Maso, Fabio Falcini, Lucia Mangone, Samuele Massarut, Laura Schirosi, Anna Crispo, Patrizia Vici, Silvia Franceschi
De-Implementation of Axillary Staging and Radiotherapy in Low-Risk Breast Cancer Patients Aged 70-79 Years from Six Italian Cancer Institutes. Current oncology (Toronto, Ont.) 30 (4) (2023)
Lauro Bucchi, Alessandra Ravaioli, Luigino Dal Maso, Fabio Falcini, Lucia Mangone, Samuele Massarut, Laura Schirosi, Anna Crispo, Patrizia Vici, Silvia Franceschi
De-Implementation of Axillary Staging and Radiotherapy in Low-Risk Breast Cancer Patients Aged 70-79 Years from Six Italian Cancer Institutes. Current oncology (Toronto, Ont.) 30 (4) (2023)
Annalisa Schirizzi, Aram Arshadi, Doron Tolomeo, Laura Schirosi, Anna Maria Valentini, Giampiero De Leonardis, Maria Grazia Refolo, Rossella Donghia, Clelia Tiziana Storlazzi, Francesco Alfredo Zito, Angela Dalia Ricci, Simona Vallarelli, Carmela Ostuni, Maria Bencivenga, Giovanni De Manzoni, Caterina Messa, Raffaele Armentano, Gianluigi Giannelli, Claudio Lotesoriere, Rosalba D'Alessandro
VEGFA Status as a Predictive Marker of Therapy Outcome in Metastatic Gastric Cancer Patients Following Ramucirumab-Based Treatment. Biomedicines 11 (10) (2023)
Lauro Bucchi, Alessandra Ravaioli, Luigino Dal Maso, Fabio Falcini, Lucia Mangone, Samuele Massarut, Laura Schirosi, Anna Crispo, Patrizia Vici, Silvia Franceschi
De-Implementation of Axillary Staging and Radiotherapy in Low-Risk Breast Cancer Patients Aged 70-79 Years from Six Italian Cancer Institutes. Current oncology (Toronto, Ont.) 30 (4) (2023)
Concetta Saponaro, Annarita Fanizzi, Margherita Sonnessa, Paolo Mondelli, Daniele Vergara, Donato Loisi, Raffaella Massafra, Agnese Latorre, Francesco A Zito, Laura Schirosi
Downstream Signaling of Inflammasome Pathway Affects Patients' Outcome in the Context of Distinct Molecular Breast Cancer Subtypes. Pharmaceuticals (Basel, Switzerland) 15 (6) (2022)